Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 13, Number 9—September 2007

Letter

Extensively Drug-Resistant Mycobacterium tuberculosis, India

Rajesh Mondal* and Amita Jain*Comments to Author 
Author affiliations: *King George’s Medical University, Lucknow, India;

Main Article

Table

Resistance pattern of XDR TB isolates*

Strain no. Resistant to first-line drugs Resistant to second-line drugs
RM 55 S, H, R, E K, O, CAP, CLA, PAS, ETH
RM 490 S, H, R, E K, O, CAP, CLA, PAS, ETH
RM 552 S, H, R, E K, O, CAP, CLA, PAS, ETH
RM 585† S, H, R, E K, O, CLA, PAS, ETH
RM 789 S, H, R, E K, O, CAP, CLA, PAS, ETH

*n = 5; XDR TB, extensively drug-resistant tuberculosis; S, streptomycin; H, isoniazid; R, rifampin; E, ethambutol; K, kanamycin; O, ofloxacin; CAP, capreomycin; CLA, clarithromycin; PAS, p– amino salicylic acid; ETH, ethionamide.
†Sensitive to capreomycin.

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO